287 related articles for article (PubMed ID: 7510297)
41. Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells.
Sperr WR; Czerwenka K; Mundigler G; Müller MR; Semper H; Klappacher G; Glogar HD; Lechner K; Valent P
Int Arch Allergy Immunol; 1993; 102(2):170-5. PubMed ID: 7691300
[TBL] [Abstract][Full Text] [Related]
42. SCF/c-kit receptor-mediated arachidonic acid liberation in rat mast cells. Involvement of PLD activation associated tyrosine phosphorylation.
Koike T; Mizutani T; Hirai K; Morita Y; Nozawa Y
Biochem Biophys Res Commun; 1993 Dec; 197(3):1570-7. PubMed ID: 7506546
[TBL] [Abstract][Full Text] [Related]
43. Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor.
Ikuta K; Ingolia DE; Friedman J; Heimfeld S; Weissman IL
Int J Cell Cloning; 1991 Sep; 9(5):451-60. PubMed ID: 1720154
[TBL] [Abstract][Full Text] [Related]
44. Hematopoietic receptors of class III receptor-type tyrosine kinases.
Rosnet O; Birnbaum D
Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
[TBL] [Abstract][Full Text] [Related]
45. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
46. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
Miyazawa K; Williams DA; Gotoh A; Nishimaki J; Broxmeyer HE; Toyama K
Blood; 1995 Feb; 85(3):641-9. PubMed ID: 7530502
[TBL] [Abstract][Full Text] [Related]
47. Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor.
Blechman JM; Lev S; Brizzi MF; Leitner O; Pegoraro L; Givol D; Yarden Y
J Biol Chem; 1993 Feb; 268(6):4399-406. PubMed ID: 7680037
[TBL] [Abstract][Full Text] [Related]
48. The riddle of the mast cell: kit(CD117)-ligand as the missing link?
Valent P
Immunol Today; 1994 Mar; 15(3):111-4. PubMed ID: 7513517
[TBL] [Abstract][Full Text] [Related]
49. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction.
Blechman JM; Lev S; Barg J; Eisenstein M; Vaks B; Vogel Z; Givol D; Yarden Y
Cell; 1995 Jan; 80(1):103-13. PubMed ID: 7529140
[TBL] [Abstract][Full Text] [Related]
50. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
Sarup JC; Johnson RM; King KL; Fendly BM; Lipari MT; Napier MA; Ullrich A; Shepard HM
Growth Regul; 1991 Jun; 1(2):72-82. PubMed ID: 1688187
[TBL] [Abstract][Full Text] [Related]
51. Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth.
Williams B; Atkins A; Zhang H; Lu D; Jimenez X; Li H; Wang MN; Ludwig D; Balderes P; Witte L; Li Y; Zhu Z
Leukemia; 2005 Aug; 19(8):1432-8. PubMed ID: 15931264
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines.
Turner AM; Bennett LG; Lin NL; Wypych J; Bartley TD; Hunt RW; Atkins HL; Langley KE; Parker V; Martin F
Blood; 1995 Apr; 85(8):2052-8. PubMed ID: 7536489
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
54. Switching of mouse spermatogonial proliferation from the c-kit receptor-independent type to the receptor-dependent type during differentiation.
Tajima Y; Sawada K; Morimoto T; Nishimune Y
J Reprod Fertil; 1994 Sep; 102(1):117-22. PubMed ID: 7528277
[TBL] [Abstract][Full Text] [Related]
55. Steel factor directs melanocyte development in vitro through selective regulation of the number of c-kit+ progenitors.
Reid K; Nishikawa S; Bartlett PF; Murphy M
Dev Biol; 1995 Jun; 169(2):568-79. PubMed ID: 7540155
[TBL] [Abstract][Full Text] [Related]
56. Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture.
Matsui Y; Toksoz D; Nishikawa S; Nishikawa S; Williams D; Zsebo K; Hogan BL
Nature; 1991 Oct; 353(6346):750-2. PubMed ID: 1719421
[TBL] [Abstract][Full Text] [Related]
57. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor.
Broudy VC; Lin N; Zsebo KM; Birkett NC; Smith KA; Bernstein ID; Papayannopoulou T
Blood; 1992 Jan; 79(2):338-46. PubMed ID: 1370384
[TBL] [Abstract][Full Text] [Related]
58. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells.
Serve H; Yee NS; Stella G; Sepp-Lorenzino L; Tan JC; Besmer P
EMBO J; 1995 Feb; 14(3):473-83. PubMed ID: 7532131
[TBL] [Abstract][Full Text] [Related]
59. The c-kit receptor transduces the stem cell factor-triggered growth signal in murine interleukin-3-dependent cell line.
Ohashi H; Kameda R; Nishikawa M; Kawagishi M; Liu YC
Cytotechnology; 1994; 16(1):27-35. PubMed ID: 7531463
[TBL] [Abstract][Full Text] [Related]
60. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
